Therapeutic Monitoring of Calcineurin Inhibitors for the Nephrologist
Top Cited Papers
Open Access
- 1 March 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 2 (2) , 374-384
- https://doi.org/10.2215/cjn.03791106
Abstract
The calcineurin inhibitors (CNI) cyclosporine and tacrolimus remain the backbone of immunosuppression for most kidney transplant recipients. Despite many years of experience, protocols that optimize efficacy with minimal toxicity remain a subject of debate. Nevertheless, studies of the pharmacokinetic properties of the CNI, particularly cyclosporine, have led to improved dosing strategies. The purpose of this article is to review the current understanding of CNI pharmacokinetics and its relevance to proper dosing and monitoring of these medications. This article also reviews the trials that have helped to define the optimal dosages and discusses the effect of adjunctive immunosuppressive agents on CNI pharmacokinetics and dosing.Keywords
This publication has 100 references indexed in Scilit:
- Evaluation of a Limited Sampling Strategy to Estimate Area Under the Curve of Tacrolimus in Adult Renal Transplant PatientsTherapeutic Drug Monitoring, 2005
- AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipientsKidney International, 2005
- Cyclosporine C2 monitoring improves renal dysfunction after lung transplantationThe Journal of Heart and Lung Transplantation, 2004
- A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients1Transplantation, 2003
- TacrolimusDrugs, 2003
- CyclosporinDrugs, 2001
- DOUBLE-BLIND COMPARISON OF TWO CORTICOSTEROID REGIMENS PLUS MYCOPHENOLATE MOFETIL AND CYCLOSPORINE FOR PREVENTION OF ACUTE RENAL ALLOGRAFT REJECTION1Transplantation, 2000
- COMPARISON OF NEORAL DOSE MONITORING WITH CYCLOSPORINE TROUGH LEVELS VERSUS 2-HR POSTDOSE LEVELS IN STABLE LIVER TRANSPLANT PATIENTS1,2Transplantation, 1998
- Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantationKidney International, 1998
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984